Liquid Biopsy Based NGS in Newly Diagnosed NSCLC
This study expands the application of an electronic health record (EHR) "nudge" used to prompt physicians' clinical practice to order molecular testing at the time of initial diagnosis for patients with specific types of advanced lung cancer. The primary goal is to have these test results available prior to starting treatment so that physicians can make molecularly-informed treatment decisions. The second goal is to better understand factors that contribute to whether or not the EHR-nudge implementation is successful.
Checked against the public recordLast updated Mar 11, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Charu Aggarwal
- Interventions being studied
- Behavioral: iNUDGE
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Participants with a histological, or cytological diagnosis of metastatic non-squamous (mNSq) non-small cell lung cancer (NSCLC) who have not yet received systemic treatment for metastatic disease. * Participants must be seen at Lancaster General Health (LGH), Penn Presbyterian Medical Center (PPMC), Penn Medicine Cherry Hill (PMCH), Penn Medicine Princeton Health (PMPH), Penn Medicine Voorhees (PMV) or Penn Medicine Washington Township (PMWT) for mNSq NSCLC. Exclusion Criteria: * Participants with incomplete staging information. * Children, pregnant women, fetuses, neonates, or prisoners are not included in this research study.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Penn Medicine Cherry HillCherry Hill, New Jersey
- Penn Medicine Princeton HealthPlainsboro, New Jersey
- Penn Medicine Washington TownshipSewell, New Jersey
- Penn Medicine VoorheesVoorhees Township, New Jersey
- Penn Medicine Lancaster General HealthLancaster, Pennsylvania
- Penn Presbyterian Medical CenterPhiladelphia, Pennsylvania
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 11, 2026. Always confirm current availability with the study team.